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INTRODUCTION
At higher exercise intensities, the increased demand for glycolysis 
leads to excessive cellular lactate production and accumulation of 
protons (H+), which need to be buffered or expelled from the 
muscle to regulate cellular pH and maintain a  fast glycolytic 
flow [1]. The 1:1 transmembrane cotransport of lactate and H+ 
is facilitated by proton-linked monocarboxylate transporters 
(MCTs) via a facilitated diffusion mechanism between different 
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ABSTRACT: The purpose of this study was to explore the association of the MCT1 gene Glu490Asp polymorphism 
(rs1049434) with athletic status and performance of endurance athletes. A total of 1,208 Brazilians (318 endurance 
athletes and 890 non-athletes) and 867 Europeans (315 endurance athletes and 552 non-athletes) were evaluated 
in a case–control approach. Brazilian participants were classified based on self-declared ethnicity to test whether 
the polymorphism was different between Caucasians and Afro-descendants. Moreover, 66 Hungarian athletes 
underwent an incremental test until exhaustion to assess blood lactate levels, while 46 Russian athletes had 
their maximum oxygen uptake ( O2max) compared between genotypes. In the Brazilian cohort, the major T-allele 
was more frequent in Caucasian top-level competitors compared to their counterparts of lower competitive level 
(P = 0.039), and in Afro-descendant athletes compared to non-athletes (P = 0.015). Similarly, the T-allele was 
more frequent in European athletes (P = 0.029). Meta-analysis of the Brazilian and European cohorts confirmed 
that the T-allele is over-represented in endurance athletes (OR: 1.48, P = 0.03), especially when Afro-descendant 
athletes were included in the meta-analysis (OR: 1.58, P = 0.005). Furthermore, carriers of the T/T genotype 
accumulated less blood lactate in response to intense effort (P < 0.01) and exhibited higher O2max (P = 0.04). 
In conclusion, the Glu490Asp polymorphism was associated with endurance athletic status and performance. 
Our findings suggest that, although ethnic differences may exist, the presence of the major T-allele (i.e., the 
Glu-490 allele) favours endurance performance more than the mutant A-allele (i.e., the 490-Asp allele).
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cells within a given muscle or between muscle and blood [2, 3]. 
The MCTs form part of the solute carrier 16 (SLC16) gene family 
that contains 14 related proteins (isoforms), wherein the first 
isoform (MCT1) is particularly important for the transport of 
lactate and one of the most well-studied and functionally charac-
terized transporters, largely due to its broader tissue distri- 
bution [4].
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Several subsequent studies assessing healthy moderately active 
men [9, 10] and elite male athletes [11, 12] demonstrated that 
those carriers of the mutant allele exhibit a higher blood lactate 
concentration after different protocols of intense exercise, as well as 
a lower decrease in blood lactate levels after physical exertion [13]. 
Furthermore, in an assessment of a Russian cohort, endurance-ori-
ented rowers showed a lower frequency of the mutant allele and the 
homozygous genotype for the mutant allele compared to the control 
group, suggesting that the major allele may be preferred for perfor-
mance [11]. However, this association was not replicated in other 
endurance athlete cohorts [14–16]. In a study assessing Brazilian 
athletes, a strong association was found between the major allele 
and power athletic status, but the endurance group did not differ 
from the control group [17].
As recently highlighted, African populations have a marked lower 
frequency of the Glu490Asp mutant allele [18]. According to the 
1000 Genomes Project Phase 3 [19], the minor allele frequency 
(MAF) in African populations ranges from 7.1% to 13.1%, whereas 
the MAF in European populations ranges from 38.9% to 47.2%. 
Moreover, a study assessing Israeli top-level runners showed that the 
MAF was significantly lower in those runners of Ethiopian origin 
compared to those of Caucasian origin or controls [20]. The homo-
zygous genotype for the mutant allele was absent among the 37 Israeli 
The MCT1 is found in almost all tissues, sometimes in conjunction 
with other MCT isoforms (e.g., in skeletal muscle) and sometimes 
as the only transporter (e.g., in erythrocytes) [5]. Erythrocytes play 
a fundamental role in supporting muscle lactate efflux because their 
rapid uptake of lactate flowing from muscle to plasma prevents the 
rise of plasma lactate levels, while maintaining a favourable gradient 
concentration difference between muscle and plasma [6]. Therefore, 
it is reasonable to assume that a deficiency in erythrocyte lactate 
transport capacity could influence the muscle metabolism during 
intense exercise. Indeed, some individuals were shown to have a re-
duced rate of erythrocyte lactate transport and consequently, a fail-
ure to decrease muscle lactate (and H+) levels normally after intense 
exercise [7, 8]. Since MCT1 is the only isoform found in erythrocytes, 
in order to identify mutations that could explain the reduced rate of 
lactate transport, Merezhinskaya et al. [8] sequenced the full-length 
MCT1 coding sequence of five individuals previously identified as 
having reduced erythrocyte lactate transport. Three coding variants 
were found; however, while two of these variants were absent or rare 
in a replication cohort, a third mutation was identified as a common 
gene polymorphism [8]. This polymorphism involves a transversion 
substitution at coding base 1470 (c.1470A > T), which converts 
amino acid #490 of the protein encoded by the MCT1 gene from 
glutamic acid to aspartic acid (p.Glu490Asp; see Figure 1).
FIG. 1. Representation of the MCT1 gene Glu490Asp polymorphism
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runners of Ethiopian origin, suggesting an association between the 
polymorphism and endurance athletes of African descent [20], which 
needs to be confirmed in larger and independent samples.
The Brazilian population is heterogeneous. After the arrival of 
millions of Europeans during the second half of the 19th century 
and the first half of the 20th century [21], the European component 
of ancestry has become uniformly predominant in Brazil [22]. Nev-
ertheless, this massive immigration of Europeans did not conceal 
some previous existing components of African ancestry [21]. There-
fore, the purpose of this study was to further explore the Brazilian 
cohort of endurance athletes to test whether the MCT1 gene Glu-
490Asp polymorphism differs between athletes and non-athletes 
according to ethnic background, using a case–control approach. 
In addition, the polymorphism was evaluated in an independent 
cohort of European endurance athletes. A secondary purpose of 
this study was to evaluate the aerobic performance of athletes with 
different Glu490Asp genotypes. We tested the hypothesis that the 
major allele (i.e., the Glu-490 allele) is preferred for endurance 
performance because, in theory, it favours the individual to sustain 
higher exercise intensities.
MATERIALS AND METHODS 
Research Design
For the case–control association study, two independent cohorts were 
used: a Brazilian cohort stratified by athletic status and self-declared 
ethnicity, and a European cohort composed of Russian and Hungar-
ian athletes of Caucasian descent. For the study of aerobic performance, 
athletes underwent a physical test to assess circulating lactate levels 
(Hungarians) or maximum oxygen uptake ( O2max; Russians). The 
Brazilian study was approved by the research ethics committee of the 
School of Physical Education and Sport, University of São Paulo, São 
Paulo, Brazil. The study performed on the Hungarian sample was 
approved by the Hungarian Ethics Committee. The study performed 
on the Russian sample was approved by the ethics committee of the 
Physiological Section of the Russian National Committee for Biologi-
cal Ethics. All procedures adopted were conducted according to the 
World Medical Association Declaration of Helsinki ethical principles 
for research involving human subjects. Written informed consent was 
obtained from all individual participants.
Subjects
Brazilian cohort: A total of 1,208 Brazilians participated in the study, 
318 of which were endurance athletes (237 men and 81 women; 
age: 28.8 ± 9.0 years), and 890 were adult non-athletic individuals 
(506 men and 384 women; age: 32.8 ± 12.3 years). The endurance 
group comprised athletes from the following sport disciplines: road 
cycling and mountain biking (n = 106), running ≥ 1,500 m (n = 51), 
rowing (n = 87), swimming ≥ 400 m (n = 18) and triathlon (n = 56). 
Those who represented Brazil in international competitions such as 
the Olympics, World or Continental Championships were classified 
as international-level athletes. Non-athletes were those never engaged 
in sports competition and were representative of the general Brazil-
ian population. These data were derived from a previous study [17].
All participants answered a questionnaire that included a multiple-
choice question about self-declared ethnicity, based on the classifica-
tion used by the Brazilian Institute of Geography and Statistics (IBGE). 
Those who self-declared as white were classified as Caucasians, 
whereas individuals self-declared as black or brown were classified 
as Afro-descendants. For those whose self-declared ethnicity is white, 
the main genomic contribution is from European ancestry, whereas 
for those whose self-declared ethnicity is black or brown, the main 
genomic contribution is from African ancestry [23]. There was a sim-
ilar proportion of Caucasians and Afro-descendants between athletes 
and non-athletes. Of the 1,208 participants, 422 were classified as 
Afro-descendants (118 athletes and 304 non-athletes, ≈ 35%), and 
786 were classified as Caucasians (200 athletes and 586 non-
athletes, ≈ 65%).
European cohort: A total of 382 Russians and 196 Hungarians 
were enrolled in the case–control study. The Russian sample was 
composed of 208  long-distance endurance athletes (age: 
22.6 ± 3.8 years) and 174 controls (age: 44.5 ± 4.1 years). 
These Russian data are independent of our previous publica-
tion [11], and included the following sport disciplines: biathlon 
(n = 60), cross-country skiing (n = 95), marathon running (n = 1), 
orienteering (n = 3), race walking (n = 9), swimming 5–25 km 
(n = 19) and triathlon (n = 21). All athletes were international-
level competitors who represented Russia in international compe-
titions and have been tested negative for doping substances. The 
control group included unrelated citizens, without any competitive 
sport experience. The Hungarian sample was composed of 107 en-
durance athletes (age: 26.1 ± 5.1 years) from the following sport 
disciplines: rowing (n = 29), canoeing (n = 39), triathlon (n = 29), 
ultramarathon (n = 5) and road cycling (n = 5), and 89 controls 
(age: 29.8 ± 8.9 years). All Hungarian athletes were national team 
members and international-level competitors. The control group 
included sedentary, healthy individuals with no competitive sport 
experience. In addition, data of European populations (n = 289) 
from the 1000 Genomes Project were included as controls. More 
specifically, data from 4 European populations that did not differ 
statistically from our control group composed of Russians and Hun-
garians (1000 Genomes population code: CEU, FIN and GBR) were 
included.
Regarding the study of aerobic performance, 66 Hungarian elite 
athletes (football players, rowers, triathletes and water polo players; 
47 men and 19 women; age: 25.4 ± 5.4 years) underwent an in-
cremental treadmill test to exhaustion to assess blood lactate levels, 
while 46 male athletes from the Russian endurance group (rowers, 
kayakers, biathletes and cross-country skiers; age 25.4 ± 3.6 years) 
and members of the Russian national teams had their O2max deter-
mined.
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accumulation was calculated by a subtraction of the resting concen-
tration from the value measured immediately after the test (i.e., 
LAacc = LAmax – LAr).
The O2max of Russian athletes was determined during an incre-
mental exercise test to exhaustion using a specific ergometer or 
a motor-driven treadmill according to the athlete’s specialty. A detailed 
description of testing protocols can be found elsewhere [26]. In all 
cases, a spiroergometry system with breath-by-breath technology 
was used to measure oxygen consumption during the entire test 
(Cortex, Leipzig, Germany). The O2max was the highest mean value 
observed over a 30 s period.
Statistical Analysis
The Chi-square test (χ2) analysis was used to evaluate Hardy-Wein-
berg Equilibrium (HWE) expectations. A deviation from HWE was 
observed when χ2 > 3.84 (i.e., P > 0.05). Genotype and allele 
frequencies were also compared using the χ2 or Fisher’s exact test 
when appropriate. To determine the strength of the associations, 
a binary logistic regression analysis was used to compare cases and 
controls under three genetic models: codominant (T/T vs. T/A or A/A), 
dominant (T/T vs. T/A+A/A) and recessive (T/T+T/A vs. A/A). Each 
logistic regression reports an odds ratio (OR), a 95% confidence 
interval (95% CI) and a P-value. A meta-analysis of the Brazilian 
and European cohorts was performed using the Review Manager 
(RevMan) computer program version 5.3. The DerSimonian and 
Laird random-effects model was used to calculate weighted OR and 
its 95% CI. The overall effect was assessed using the Z score with 
the significance level established at P < 0.05. Heterogeneity between 
studies was assessed using the Cochran Q test (χ2).
Blood lactate levels between genotypes were compared using 
one-way analysis of variance (ANOVA) and Tukey post hoc test. For 
the comparison under the recessive model, the difference between 
means was compared using an unpaired t-test. Spearman correlation 
(non-parametric) was used to evaluate the relationship between 
O2max and genotypes, which were coded as a dummy variable, as 
follows: A/A = 1, T/A = 2 and T/T = 3. Differences with P < 0.05 
were considered significant. Statistical analyses were performed us-
ing SPSS software version 22.0 (IBM Corp., Armonk, NY, USA) or 
GraphPad Prism version 6.01 (GraphPad Software, San Diego, CA, 
USA) was used.
RESULTS 
The genotype distribution of the Glu490Asp polymorphism met the 
HWE expectations in Brazilians for both self-declared ethnicities. 
Furthermore, there was no statistical evidence of heterogeneity 
within the general Brazilian population. Genotype distribution was 
not significantly different in non-athletes according to self-declared 
ethnicity (χ2 = 2.53, P = 0.283), nor was the allele frequency 
(P = 0.123). Table 1 shows the genotype distribution and allele 
frequency of the polymorphism in the Brazilian cohort. Genotype 
distribution and allele frequency did not differ between non-athletes 
DNA extraction and genotyping
The genomic DNA of the Brazilians was isolated from buccal epithe-
lial cells obtained from mouthwashes with a 0.9% saline solution 
prepared with DNA- and DNAse-free water and extracted using chlo-
roform followed by alcohol precipitation. The rs1049434 was geno-
typed using a pre-designed specific TaqMan® SNP Genotyping Assay 
(Applied Biosystems, Foster City, CA, USA) according to the manu-
facturer’s instructions and using a Rotor-Gene Q PCR cycler (Qiagen, 
Hilden, Germany). The VIC dye-labelled probe indicates the genom-
ic A-allele, and the FAM dye-labelled probe indicates the genomic 
T-allele. An increase in VIC or FAM fluorescent signal indicates ho-
mozygosity for the VIC- or FAM-specific allele, while an increase in 
both signals indicates heterozygosity. A scatter plot showing the 
endpoint fluorescence signals was used to discriminate the genotypes.
The TaqMan assay describes the genomic alleles instead of the 
transcript alleles (i.e., based on the coding sequence; Figure 1), 
which were described in initial studies [8, 9] and other previous 
studies [11, 15, 24] with a genotyping procedure based on conven-
tional PCR. Here, the genomic alleles were described similar to the 
method used by the 1000 Genomes Project [19]. It is worth noting 
that the transcript alleles are complementary (and inverse) to the 
genomic alleles and can cause some confusion in the interpretation 
of the data. Therefore, the amino acid change (i.e., Glu490Asp) was 
taken into account when appropriate to avoid misinterpretation [25].
The genomic DNA of the Russian samples was isolated from 
leukocytes (venous blood). DNA extraction and purification were 
performed using a commercial kit according to the manufacturer’s 
instructions (Technoclon, Moscow, Russia). The rs1049434 was 
genotyped using HumanOmni1-Quad BeadChips (Illumina Inc., Hay-
ward, CA, USA) according to the instructions of the Infinium High-
Density Assay. The genomic DNA of the Hungarian samples was 
isolated from EDTA stabilized blood using a commercial kit accord-
ing to the manufacturer’s instructions (QIAamp DNA kit, Qiagen, 
Hilden, Germany). The rs1049434 was genotyped using the Taq-
Man® SNP Genotyping Assay pre-loaded on OpenArray™ plates and 
using the OpenArray™ NT Cycler System (BioTrove Inc., Pleasanton, 
CA, USA). In both Russian and Hungarian samples, genotypes were 
described based on the genomic alleles as used in the Brazilian 
sample.
Performance analysis
To assess the blood lactate levels of Hungarian athletes, an incre-
mental test was performed on a treadmill. A modified Bruce protocol 
was applied, in which the test started with a speed of 8 km/h and 
increased by 2 km/h after 2 minutes. Thereafter, the exercise inten-
sity was increased by adjusting the treadmill incline by 1.5% every 
minute until volitional exhaustion. Capillary blood lactate (mmol/L) 
was drawn from the ear lobe before (LAr), immediately after (LAmax) 
and 5 minutes after (LA5) the interruption of the exercise for the 
assessment of the lactate concentration (Biosen C-Line Lactate 
analyzer, EKF Diagnostics, Cardiff, United Kingdom). The blood lactate 
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and Caucasian athletes as a whole. However, further analysis of the 
Caucasian endurance group showed an intragroup difference. Cau-
casian international-level competitors had a lower frequency of the 
A/A genotype compared to Caucasian national- or regional-level com-
petitors (14.5% vs. 19.4% vs. 22%, P = 0.034). Consequently, the 
major T-allele was more frequent in Caucasian international-level 
athletes compared to their counterparts of lower competitive level 
(63% vs. 59% vs. 57%, P = 0.039), that is, there is a progressive 
increase in the frequency of the T-allele as the competitive level in-
creases.
Regarding Afro-descendant athletes, they differed from the gen-
eral population, especially under the recessive model (i.e., T/T+T/A 
vs. A/A genotypes). The A/A genotype was underrepresented in Afro-
descendant athletes. Afro-descendant carriers of the A/A genotype 
rather than T/T+T/A had a decreased odds ratio of being an endurance 
athlete compared with non-athletes (OR: 0.48, 95% CI: 0.24–0.97, 
P = 0.04). The A/A genotype was even more underrepresented in 
Afro-descendant international-level athletes. The genotype distribution 
in Afro-descendant international-level athletes was: T/T = 51.0%, 
T/A = 44.9% and A/A = 4.1% (n = 49), and the presence of the 
A/A genotype rather than T/T decreased the odds ratio of being an 
international-level endurance athlete compared with non-athletes (OR: 
0.21, 95% CI: 0.05–0.89, P = 0.034). A similar trend was observed 
when comparing Afro-descendant international-level athletes and 
Afro-descendant non-athletes (A/A vs. T/T; OR: 0.26, 95% CI: 
0.06–1.16, P = 0.078). Therefore, the major allele was more frequent 
in Afro-descendant athletes, especially in international-level athletes. 
The T-allele was found in only 61.8% of non-athletes compared to 
69.9% of Afro-descendant athletes (P = 0.015) or 73.5% of Afro-
descendant international-level athletes (P = 0.02).
The genotype distribution of the Glu490Asp polymorphism also 
met the HWE expectations in Europeans. Table 2 shows the genotype 
distribution and allele frequency of the polymorphism in the Euro-
pean cohort. The presence of the A/A genotype (recessive model; 
OR: 0.61, 95% CI: 0.41–0.92, P = 0.019) decreased the odds 
ratio of being an endurance athlete. Therefore, the major T-allele was 
more frequent in European athletes (P = 0.029). Meta-analysis of 
the Brazilian (Caucasians) and European cohorts confirmed that 
carriers of the T-allele (i.e., T/T+T/A genotypes) are over-represented 
in Caucasian endurance athletes (OR: 1.48), while the A/A genotype 
is under-represented (OR: 0.68, P = 0.03). Moreover, the associa-
tion became stronger when Afro-descendant athletes were included 
in the meta-analysis (Table 3). There was no statistical evidence of 
heterogeneity between cohorts.
TABLE 1. Genotype distribution and allele frequency of the MCT1 gene Glu490Asp polymorphism in the Brazilian cohort according to 
self-declared ethnicity.
Status Group n
Genotypes (%) Alleles (%)
T/T T/A A/A T-allele A-allele
Control Caucasian non-athletes 586 36.9 47.3 15.9 60.5 39.5
Control Afro-descendant non-athletes 304 41.1 46.4 12.5 64.3 35.7
Control Non-athletes† 890 38.3 47.0 14.7 61.8 38.2
Endurance Caucasian athletes 200 38.0 43.5 18.5 59.8 40.2
Endurance Afro-descendant athletes 118 47.5 44.9 7.6 a 69.9 30.1 a
Genotypes were described based on the genomic alleles. † Pooled data of non-athletes (i.e., this group includes data from both self-
declared ethnicities). a The genotype distribution (Codominant model: χ2 = 6.08, P = 0.048) and allele frequency (P = 0.015) in 
Afro-descendant athletes were significantly different from those of non-athletes.
TABLE 2. Genotype distribution and allele frequency of the MCT1 gene Glu490Asp polymorphism in the European cohort.
Status Group n
Genotypes (%) Alleles (%)
T/T T/A A/A T-allele A-allele
Control Non-athletes 552 35.3 47.3 17.4 59.0 41.0
Endurance Athletes 315 40.0 48.6 11.4 a 64.3 35.7 a
Genotypes were described based on the genomic alleles. a The genotype distribution (Codominant model: χ2 = 5.94, P = 0.05) and 
allele frequency (P = 0.029) in endurance athletes were significantly different from those of non-athletes.
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Table 4 shows the blood lactate levels of Hungarian athletes with 
different Glu490Asp genotypes and subjected to an incremental test 
until exhaustion. Carriers of the A/A genotype showed higher lactate 
accumulation during exercise and a greater peak 5 minutes after 
maximum effort, as evidenced by the analysis under the recessive 
model (T/T+T/A vs. A/A). On the other hand, the major T-allele was 
positively correlated with O2max (ml·kg-1·min-1) in Russian male 
endurance athletes, with the T/T genotype showing the highest val-
ues (T/T = 66.3 ± 6.2, n = 14; T/A = 62.5 ± 7.3, n = 23; 
A/A = 61.4 ± 7.1, n = 9; r = 0.3, P = 0.04), as shown in Figure 2.
DISCUSSION 
In the present study, we explore the relevance of the MCT1 gene 
Glu490Asp polymorphism (also known as A1470T; rs1049434) for 
endurance athletes. The main finding of the present study was that 
the major T-allele (i.e., the Glu-490 allele) is associated with athletic 
TABLE 3. Meta-analysis of the association between MCT1 gene Glu490Asp polymorphism and endurance athletic status.
Group
Total number T/T + T/A genotypes A/A genotype
Athletes Controls OR (95% CI) OR (95% CI)
Caucasian Brazilians† 77 586 1.13 (0.58–2.22) 0.88 (0.45–1.74)
European Cohort 315 552 1.63 (1.08–2.46) 0.61 (0.41–0.92)
Total 392 1138 1.48 (1.04–2.10) 0.68 (0.48–0.96)
Test for overall effect – – Z = 2.18 (P = 0.03) Z = 2.18 (P = 0.03)
Heterogeneity – – χ² = 0.82 (P = 0.36) χ² = 0.82 (P = 0.36)
Brazilian Cohort‡ 195 890 1.51 (0.92–2.49) 0.66 (0.40–1.09)
European Cohort 315 552 1.63 (1.08–2.46) 0.61 (0.41–0.92)
Total 510 1442 1.58 (1.15–2.17) 0.63 (0.46–0.87)
Test for overall effect – – Z = 2.83 (P = 0.005) Z = 2.83 (P = 0.005)
Heterogeneity – – χ² = 0.06 (P = 0.81) χ² = 0.06 (P = 0.81)
† Only data from Caucasian international-level athletes were considered for the meta-analysis, given that a difference was identified 
between Caucasian athletes of international-level and their counterparts of lower competitive level. ‡ Data from Afro-descendant Brazilians 
were added to the previous analysis, containing only Caucasian Brazilians. All Afro-descendant athletes were considered for the meta-
analysis.
TABLE 4. Blood lactate responses (mmol/L) of Hungarian athletes before (LAr), immediately after (LAmax) and 5 minutes after (LA5) to 
an incremental treadmill test until exhaustion.
Genotypes (n) P-values
T/T (26) T/A (34) A/A (6) Codominant Recessive
LAr 1.52 ± 0.62 1.60 ± 0.40 1.46 ± 0.06 0.89 0.75
LAmax 8.5 ± 1.40 9.88 ± 1.18 13.6 ± 2.26  < 0.01  < 0.01
LA5 11.00 ± 3.67 11.59 ± 3.95 17.50 ± 1.98 0.11 0.04
LAacc 6.98 ± 1.13 8.27 ± 1.20 12.14 ± 2.32  < 0.01  < 0.01
Genotypes were described based on the genomic alleles. Values are expressed as mean ± SD. LAacc (blood lactate accumulation) = LAmax – 
LAr.
FIG. 2. VO2 max in Russian athletes.
Biology of Sport, Vol. 38 No3, 2021   471
MCT1 gene Glu490Asp polymorphism and endurance performance
status and performance. Meta-analysis of 510 endurance athletes 
compared with 1,442 non-athletes showed that carriers of the Glu-
490 allele were more likely to be an athlete. In particular, the con-
sideration of Afro-descendant athletes made the association stronger.
In the initial study of Merezhinkaya et al. [8], three of five indi-
viduals with marked reductions in the rate of erythrocyte lactate 
transport were carriers of the Glu490Asp mutant allele: two homo-
zygotes and one heterozygote. Interestingly, one homozygote was 
a black male with ≈ 51% reduced erythrocyte lactate transport, 
whereas the other homozygote was a white male with ≈ 34% reduced 
erythrocyte lactate transport; the heterozygote was a black male with 
≈ 41% reduced transport [8]. Therefore, the black male homozygous 
for the mutant allele showed greater lactate transport deficit than the 
white male homozygous for the mutant allele, although with the 
available data was not possible to state whether this is an effect of 
ethnicity or other variables (e.g., age or training status). More re-
cently, it was found that Caucasian non-athletes [9, 10], Caucasian 
athletes [11] and Japanese athletes [12] carriers of the mutant allele 
exhibit a higher blood lactate concentration after intense exercise, 
which is in line with the current study of Hungarian athletes. How-
ever, to date, no study has evaluated the extent of the influence of 
this polymorphism on lactate response to intense exercise in Afro-
descendant individuals.
Differences in the responses to endurance exercise between African 
or Afro-descendants and Caucasians have been evaluated mainly 
among runners, where compelling evidence indicates that African/
Afro-descendant distance runners exhibit lower blood lactate concen-
trations during exercise [27–31] and superior fatigue resistance [27, 31]. 
African runners’ exhibit a lower plasma lactate accumulation, which 
means that these athletes accumulate lactate at a slower rate as the 
exercise intensity increases [31]. This difference is clearer at higher 
running intensities, performed at or above 80% of maximum inten-
sity [28, 29], as well as after maximum exertion [32]. These near-
maximal efforts are commonly applied by well-trained endurance 
athletes running distances ranging from 5,000 m to the marathon [33], 
and plasma lactate levels are an important indicator of the individual 
ability to sustain intense exercise [34, 35]. Therefore, the lower plas-
ma lactate accumulation observed in African/Afro-descendant runners 
may be an inherent trait that, in part, is the advantage that these 
individuals have over Caucasians [28]. The lower frequency of the 
Glu490Asp mutant allele and the homozygous genotype for the mu-
tant allele in African populations (as indicated by the 1000 Genomes 
Project) and Afro-descendant athletes ([20] and the present study) 
were consistent with this hypothesis. The mutant allele frequency in 
Brazilian Afro-descendants is not as low as that observed in African 
populations, probably due to the considerable admixture of Brazilians; 
however, its frequency was lower among Afro-descendant athletes.
There are critical factors for MCT1 function, such as activation of 
transporter and substrate affinity [36]. Topology predictions suggest 
that the MCT1 protein (like all other MCT isoforms) has 
12 transmembrane-spanning helices with intracellular terminal 
domains: the N-terminal domain, important for membrane insertion 
and correct structure maintenance, and the C-terminal domain, im-
portant for the determination of substrate specificity [36]. Since the 
Glu490Asp polymorphism is just ten amino acids from the C-termi-
nus (amino acid #500), it is assumed that this gene variant may 
affect the substrate specificity and transport activity.
Indeed, the Glu490Asp polymorphism was shown to affect the 
transporter activity, given that the negatively charged 490-Asp allele 
was shown to lead to a change in the transporter conformation and 
a reduction in transporter-substrate affinity [37]. A reduced affinity 
of MCT1 for lactate may limit its rate of transport and cause plasma 
lactate accumulation [3, 4], especially when considering skeletal 
muscle fibre-type proportions and metabolic enzyme activities of the 
individual. Some studies have shown that Africans may have a high-
er percentage of type IIa fibres [29, 32, 38], which can serve as 
important power generators for the high intensities applied by well-
trained endurance athletes [31]. However, type IIa fibres have high-
er glycolytic enzyme activities and greater ability to produce lactate 
relative to type I fibres [39, 40]. Based on this, Afro-descendant 
athletes are able to produce equal or even more muscle lactate, al-
though they may have lower plasma lactate levels during exer-
cise [28]. Since a less efficient metabolism could raise plasma lactate 
levels in those most susceptible to its production, the Glu-490 allele 
is probably part of a genetic architecture that prevents plasma lactate 
accumulation in Afro-descendant athletes, favouring the maintenance 
of intense endurance exercise, and therefore, is more frequent in 
these individuals.
On the other hand, some evidence suggests that Caucasians may 
have a higher percentage of type I fibres [27, 29, 31, 38], which 
have higher capillary density and greater abundance of mitochondria 
and oxidative enzymes than type II fibres [40]. Moreover, there is 
a positive linear relationship between percentage of type I fibres and 
MCT1 content [41]. Since the biological effect of the mutant allele 
becomes evident at higher lactate levels [7], when a saturation phe-
nomenon for lactate transport can create a tendency for lactate ac-
cumulation [3], it is reasonable to assume that a favourable back-
ground could prevent lactate levels from rising and the 490-Asp 
allele interference, especially in highly trained individuals. Notwith-
standing, the above explanation does not rule out that the Glu-490 
allele is advantageous for Caucasian individuals, as evidenced by the 
meta-analysis and performance tests on Caucasian athletes (blood 
lactate and O2max analysis).
In an assessment of Caucasian endurance athletes, we found an 
association between MCT1 genotypes and O2max, with the homo-
zygous genotype for the Glu-490 allele (T/T genotype) showing the 
highest values. Since there is a positive correlation between O2max 
and endurance-related phenotypes [42], the ≈ 7% higher value in 
homozygotes for the Glu-490 allele is not negligible. As oxygen con-
sumption increases linearly with exercise intensity, individuals with 
higher O2max could reach and sustain higher exercise intensities 
prior to excessive lactate accumulation and fatigue [43], which is 
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clarification becomes important. Different designations have the po-
tential to confuse the interpretation of published data if not adequate-
ly described. For example, recently Onali et al. [18] conducted an 
interesting study describing the higher frequency of the Glu-490 
allele in African populations compared with other world regions, but 
there was a misconception when comparing data from the 1000 
Genomes Project (based on the genomic alleles) with associations 
previously described in athlete cohorts (based on the transcript al-
leles)–opposite alleles were considered the same.
In conclusion, the major allele of the Glu490Asp polymorphism 
found in the MCT1 gene was associated with endurance athletic 
status, lower lactate accumulation during intense endurance exercise 
and higher O2max. Based on the present findings, it is plausible to 
assume that the presence of the major allele (i.e., the Glu-490 allele) 
favours endurance performance more than the mutant allele (i.e., 
the 490-Asp allele). Nonetheless, the physiological mechanisms 
underlying the polymorphism still need to be better explored, taking 
into account that differences between ethnicities may exist. Once 
these mechanisms are better elucidated, nutritional strategies to 
control cellular and blood pH and appropriate training programmes 
can be used accordingly. It is noteworthy that other factors can 
contribute to lower lactate and pH levels during exercise. Each of 
these traits has its own genetic predisposition, which can vary based 
on population background and environmental stimuli.
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typically accompanied by H+ accumulation, resulting in cellular and 
blood acidosis [44]. Assuming that individuals homozygous for the 
Glu-490 allele have an inherent increased plasma lactate removal 
capacity, these individuals are expected to have superior fatigue 
resistance and higher O2max, regardless ethnicity. However, it appears 
reasonable to surmise that this effect may be lower in Caucasians 
or restricted to specific groups of Caucasian athletes. Consequently, 
when using larger samples and varied approaches, the association 
is found. Further studies including molecular, biochemical or physi-
ological analyses will be of paramount importance to better elucidate 
the functional underpinnings of the Glu490Asp polymorphism in 
lactate metabolism and endurance performance among individuals 
with different biological backgrounds.
The main limitation of this study was the statistical power of some 
individual comparisons. Although the study involved 510 athletes and 
1,442 non-athletes, when stratified by ethnicity or competitive level, 
the available sample size was not adequate for powerful comparisons. 
For example, doubling the size of the Brazilian sample would be more 
appropriate. However, it is noteworthy that the athletes evaluated are 
representative of the best Brazilian competitive scenario. For the Eu-
ropean cohort, we used data from European populations as controls 
to increase our statistical power. In the absence of this data retrieved 
from the 1000 Genomes Project, we would have a low ratio of cases 
to controls. Although these controls are not exactly from the same 
regions of the athletes evaluated, we performed the χ2 to assess the 
heterogeneity of proportions to ensure that this procedure did not 
affect the association tests. Only data consistent with our cohort were 
used. Taken together, the meta-analysis of all cohorts provided a broad-
er view of the association between the Glu490Asp polymorphism and 
endurance athletic status.
It is worth mentioning that this study was based on the genomic 
reference sequence, that is, the major T-allele represents the Glu-490 
allele, whereas the minor (or mutant) A-allele represents the 490-Asp 
allele. Since alleles can be assigned in the opposite way depending 
on the reference used (i.e., the genomic or transcript alleles), this 
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